SUMMARY
Abnormalities of plasma potassium concentration ([K
]) are a common problem in patients undergoing major surgery and in those requiring intensive care. Treatment is empirical, depending on frequent blood sampling to follow the response to therapy. Even with the rapid results available from potassium ion-selective electrodes, correction of abnormalities and maintenance of a stable plasma [K + ] may be difficult. Automatic feedback control may provide a system for rapid, safe correction of plasma [K + ]. This paper describes such a system, and its use in experimental animals.
MATERIALS AND METHODS

Continuous monitoring of plasma potassium
Plasma potassium was monitored continuously in the femoral artery by means of a 1-mm o.d. valinomycin-based catheter-tip ion-selective electrode ( fig. 1 ) [1] inserted into the femoral artery. The internal reference electrode was a silversilver chloride electrode and the internal filling solution was potassium chloride 100 mmol litre" 1 . The external reference electrode was a silversilver chloride electrode contained in the barrel of a 1-ml syringe which was plugged into a salinefilled catheter in the femoral vein on the same side. This system has been shown to give reliable recordings which are relatively free from interference, and also has a response time of less than 1 s [2] . All electrodes used had a response of at least 95% of that predicted by the Nernst equation.
The electrode output was fed to an amplifier and subsequently passed through a simple RC filter with a cut-off frequency of 0.27 Hz. This signal was sampled at 10-s intervals using a 12-bit a/d convenor in the computer. Additional filtering was performed digitally by averaging the present sample with the previous average.
The electrode was calibrated by immersion in aqueous standard solutions before use, to yield the electrode response slope, and a one-point cali- 1 from that measured by the indwelling electrode. Usually, the animal was heparinized, to prevent clot formation on the electrode tip.
Control algorithm and infusion system
The control algorithm was written in BASIC on an IBM personal computer, and used a conventional proportional-integral-differential system with separate control equations for the potassium chloride infusion and the glucoseinsulin infusion. The control system was arranged so that one infusion declined to zero when the other infusion started, so that both infusions were not running simultaneously. The program also produced a screen display ( fig. 3 ). This was updated every 1 min to display the changes over the previous 40 min in
, urine flow (ml h" 1 ) and potassium excretion rate (mmol kg" 1 h" 1 ). The last two were obtained from a Vitalmetrics electronic urine meter and a flow-through potassium ion-selective electrode (Ionetics) in the urine outflow. The screen display also gave the current status of the infusion pumps and their rates (ml h" 1 ), in addition to the current value of all the graphic displays. ] at each set-point (SD of 120 readings over 2 h). Other information available included the total amount of potassium chloride given to achieve and maintain the higher set-point; the amount of insulin given during maintenance of the higher set-point; the total amount of insulin given to achieve and maintain the lower set-point; the amount of potassium chloride given during maintenance of the lower set-point; total volume of fluid infused; total volume of urine excreted. The following may also be obtained in graphic form: plasma [K + ], urine flow, potassium excretion rate, total infusion rate, potassium chloride infusion rate and insulin infusion rate.
Two sets of controller constants were used (table I). In controller A the constants were relatively conservative and the concentration of infused potassium chloride was 50 mmol litre" 1 , while in controller B the concentration of infused potassium chloride was 200 mmol litre" 1 . A more concentrated infusion was used in the latter case to prevent infusion of large volumes of fluid, perhaps provoking a diuresis and loss of potassium. The glucose-insulin infusion was identical in each case. Three dogs were studied in each group. 
RESULTS
Electrode drift and interference were not a problem: recalibration was required, at most, twice during the 6-h experiment, and occasionally not at all. Synchronizing the two control equations when the concentration was near the set-point was not a problem, and the two infusions did not run simultaneously for longer than 3 or 4 min. The performance criteria of the two controllers are given in table II. Mean resting plasma [K + ] was similar in the two groups. The major difference in performance between the two controllers was in the response rate at the higher set- point, controller B giving a considerably faster response. There was no marked difference between the two controllers in mean or SD [K + ] at either set-point, or in response rate at the lower set-point. Table III shows that controller B caused more side-effects at the lower set-point: urine output was inappropriately increased, more potassium chloride had to be given to prevent [K + ] decreasing to less than 3.0 mmol litre" 1 , and more sodium bicarbonate had to be given to correct acidosis.
One monitoring of plasma [K + ], ideally in arterial blood. The catheter-tip ion-selective electrode used for this purpose is an established research tool [1, 3] and can give reliable, low-drift recordings for several hours [2] . The use of automatic computerized control systems has been explored for the control of administration of neuromuscular blockers [4] , sodium nitroprusside [5] and volatile anaesthetics [6] . As far as we are aware, control of plasma electrolyte concentrations has not been described previously.
The results presented here show that such a system is possible to construct: monitoring of plasma [ ] was slower, as the response depended on a physiological action and not a simple chemical change. Also, the response rate was not increased by using the faster rates of infusion of insulin in controller B. Clearly, above a certain rate, the rate of infusion of insulin does not determine the rate of reduction in plasma [K + ], and the controller constants governing the insulin infusion could almost certainly be made even more conservative than in controller A. Indeed, a faster insulin infusion rate led to greater problems: urine output was inappropriately increased (probably an osmotic diuresis), more alkali was required to correct acidosis, and more potassium chloride was required to prevent plasma [K + ] decreasing to less than 3.0 mmol litre" 1 . This last problem was surprising, as insulin is cleared from the circulation rapidly [7] . There is evidence [8] that the action of insulin on plasma [K + ] persists after it has been cleared from plasma, and the results presented here provide further evidence for this.
It seems that the controller constants governing the potassium chloride infusion may be varied within wide limits depending on the desired response rate. For example, controller B gives a response close to the fastest which would be clinically desirable, without undesirable overshoot but with possibly unacceptable oscillations; it is possible that these oscillations may be reduced or eliminated by using a shorter control interval. In contrast, controller A gave a smoother increase in plasma [K + ] without oscillations, but the change was too slow for many clinical situations. The system governing plasma [K + ] reduction behaved differently. The response rate of 50 min, described here, appears to be the fastest which can be achieved because of physiological limitations. There is probably an optimum infusion rate of the glucose-insulin mixture, which should be easy to define: it would certainly be no faster than the rate given by controller A (insulin 1 u kg" 1 h" 1 ).
